Response to the letter from Warren et al

Cardiovasc Res. 2017 Dec 1;113(14):1799-1800. doi: 10.1093/cvr/cvx200.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Anti-Arrhythmia Agents
  • Calcium-Calmodulin-Dependent Protein Kinase Type 2*
  • Calmodulin*
  • Cell Communication
  • Heart

Substances

  • Anti-Arrhythmia Agents
  • Calmodulin
  • Calcium-Calmodulin-Dependent Protein Kinase Type 2